Prostate Cancer - Results from #1000

Increased frequency of CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression without inducing homologous recombination deficiency. April 23, 2024

p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer. April 22, 2024

Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles. April 22, 2024

Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. April 22, 2024

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial. April 22, 2024

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance. April 22, 2024

Dietary Fiber Intake and Risk of Advanced and Aggressive Forms of Prostate Cancer: A Pooled Analysis of 15 Prospective Cohort Studies. April 22, 2024

RECIP 1.0 Predicts Progression-Free Survival After [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer. April 22, 2024

Development of a Visually Calculated SUVmean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to 177Lu-PSMA Therapy: Comparison with Quantitative SUVmean and Patient Outcomes. April 22, 2024

The Future State of Race/Ethnicity in Urology: Urology Workforce Projection From 2021-2061 April 19, 2024

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models. April 19, 2024

BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancer. April 19, 2024

Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to overcome resistance to immune checkpoint blockade therapy. April 19, 2024

Patient-centred pathology reporting improves patient experience and understanding of disease in prostate cancer care. April 19, 2024

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer. April 19, 2024

Same-day post-therapy imaging with a new generation whole-body digital SPECT/CT in assessing treatment response to [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer. April 19, 2024

The impact of pre-biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review. April 19, 2024

Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy. April 19, 2024

Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer April 18, 2024

Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers. April 18, 2024

Page 51 of 1435